What we do




Our Portfolio


Terasaki Research Institute's portfolio tackles the biggest problems related to organ transplant. Within our key research themes we are focused on solving problems in new ways, prototyping tangible solutions, and bringing our innovation to the real-world. We work to reduce the time to innovation through use of aglie project planning. We work with partners worldwide to address three critical problems that face transplant today- transplant failure, not enough organs for patients with chronic disease, and subpar quality of life for a transplant patient. 


Our Themes

End Transplant Failure

Poor long-term survival of a transplanted organ (allograft) is one of the major problems in transplant today. We believe that we can end transplant failure and make a patient's first transplant last as long as he/she needs it to last. We design and implement research and clinical trials to better understand and fix the causes of transplant failure.

Our strategies for this theme:
Improve the drug development process.
Prevent donor specific anti-HLA antibodies.
Improve immunosuppression medication adherence.



Ensure an Optimal Life for Transplant Patients

We want to make transplant care, transplant medications, and the entire transplant process better fit the needs of the transplant patients. We are creating direct-to-patient solutions, working to establish patient reported outcomes in clinical trials and everyday clinical practice, and making sure that each patient reaches the life he or she hopes for after transplant.

Our strategies for this theme:
Move patient reported outcomes to the forefront of transplant.
Understand the symptoms and side effects of medications.
Better understand the quality of life changes in a transplant patient's life.



Prevent Patient From Progressing to Organ Failure

We are working to prevent patients from dying while waiting for an organ transplant. We believe that we need to do a better job preventing transplant from being needed. We are creating education, prevention, and allocation strategies (i.e. education, therapeutics, engineering) for patients at all stages of organ dysfunction and failure.

Our strategies for this theme:
Improve dissemination of transplant education.
Predicting transplantability and mortality.
Understanding intestinal failure.



logo bottom